Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

HM Kantarjian, S O'Brien, P Anderlini, M Talpaz

Blood (1996) 87 (8): 3069–3081.

https://doi.org/10.1182/blood.V87.8.3069.bloodjournal8783069

Published: 1996

Journal Articles

The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

J Cortes, SM O'Brien, S Pierce, MJ Keating, EJ Freireich, HM Kantarjian

Blood (1995) 86 (6): 2091–2097.

https://doi.org/10.1182/blood.V86.6.2091.bloodjournal8662091

Published: 1995

Journal Articles

Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment

DC Seong, HM Kantarjian, JY Ro, M Talpaz, J Xu, JR Robinson, AB Deisseroth, RE Champlin, MJ Siciliano

Blood (1995) 86 (6): 2343–2349.

https://doi.org/10.1182/blood.V86.6.2343.bloodjournal8662343

Published: 1995

Journal Articles

p16INK4A and p15INK4B gene deletions in primary leukemias

MA Haidar, XB Cao, T Manshouri, LL Chan, A Glassman, HM Kantarjian, MJ Keating, MS Beran, M Albitar

Blood (1995) 86 (1): 311–315.

https://doi.org/10.1182/blood.V86.1.311.bloodjournal861311

Published: 1995

Journal Articles

Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia

CF Verschraegen, M Talpaz, CF Hirsch-Ginsberg, R Pherwani, MB Rios, SA Stass, HM Kantarjian

Blood (1995) 85 (10): 2705–2710.

https://doi.org/10.1182/blood.V85.10.2705.bloodjournal85102705

Published: 1995

Journal Articles

Chronic myelogenous leukemia: a concise update

HM Kantarjian, A Deisseroth, R Kurzrock, Z Estrov, M Talpaz

Blood (1993) 82 (3): 691–703.

https://doi.org/10.1182/blood.V82.3.691.691

Published: 1993

Journal Articles

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia

HM Kantarjian, M Beran, A Ellis, L Zwelling, S O'Brien, L Cazenave, C Koller, MB Rios, W Plunkett, MJ Keating

Blood (1993) 81 (5): 1146–1151.

https://doi.org/10.1182/blood.V81.5.1146.1146

Published: 1993

Journal Articles

2-Chlorodeoxyadenosine in the treatment of multiple myeloma [letter] [see comments]

MA Dimopoulos, HM Kantarjian, EH Estey, R Alexanian

Blood (1992) 80 (6): 1626.

https://doi.org/10.1182/blood.V80.6.1626a.1626a

Published: 1992

Journal Articles

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia

HM Kantarjian, EH Estey, S O'Brien, E Anaissie, M Beran, MB Rios, MJ Keating, J Gutterman

Blood (1992) 79 (4): 876–881.

https://doi.org/10.1182/blood.V79.4.876.876

Published: 1992

Journal Articles

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

EH Estey, R Kurzrock, HM Kantarjian, SM O'Brien, KB McCredie, M Beran, C Koller, MJ Keating, C Hirsch-Ginsberg, YO Huh

Blood (1992) 79 (4): 882–887.

https://doi.org/10.1182/blood.V79.4.882.882

Published: 1992

Journal Articles

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia

HM Kantarjian, M Talpaz, K Dhingra, E Estey, MJ Keating, S Ku, J Trujillo, Y Huh, S Stass, R Kurzrock

Blood (1991) 78 (9): 2411–2418.

https://doi.org/10.1182/blood.V78.9.2411.2411

Published: 1991

Journal Articles

Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy [see comments]

HM Kantarjian, C Hirsch-Ginsberg, G Yee, Y Huh, EJ Freireich, S Stass

Blood (1990) 76 (4): 808–813.

https://doi.org/10.1182/blood.V76.4.808.808

Published: 1990

Journal Articles

Fludarabine therapy in macroglobulinemic lymphoma

HM Kantarjian, R Alexanian, CA Koller, R Kurzrock, MJ Keating

Blood (1990) 75 (10): 1928–1931.

https://doi.org/10.1182/blood.V75.10.1928.1928

Published: 1990

Journal Articles

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

EH Estey, D Dixon, HM Kantarjian, MJ Keating, K McCredie, GP Bodey, R Kurzrock, M Talpaz, EJ Freireich, AB Deisseroth

Blood (1990) 75 (9): 1766–1769.

https://doi.org/10.1182/blood.V75.9.1766.1766

Published: 1990

Journal Articles

Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course

R Kurzrock, HM Kantarjian, M Shtalrid, JU Gutterman, M Talpaz

Blood (1990) 75 (2): 445–452.

https://doi.org/10.1182/blood.V75.2.445.445

Published: 1990

Journal Articles

Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction

MS Lee, A LeMaistre, HM Kantarjian, M Talpaz, EJ Freireich, JM Trujillo, SA Stass

Blood (1989) 73 (8): 2165–2170.

https://doi.org/10.1182/blood.V73.8.2165.2165

Published: 1989

Journal Articles

Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia

A LeMaistre, MS Lee, M Talpaz, HM Kantarjian, EJ Freireich, AB Deisseroth, JM Trujillo, SA Stass

Blood (1989) 73 (4): 889–891.

https://doi.org/10.1182/blood.V73.4.889.889

Published: 1989

Journal Articles

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia

HM Kantarjian, RS Walters, TL Smith, MJ Keating, B Barlogie, KB McCredie, EJ Freireich

Blood (1988) 72 (5): 1784–1789.

https://doi.org/10.1182/blood.V72.5.1784.1784

Published: 1988

Journal Articles

Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction

MS Lee, KS Chang, EJ Freireich, HM Kantarjian, M Talpaz, JM Trujillo, SA Stass

Blood (1988) 72 (3): 893–897.

https://doi.org/10.1182/blood.V72.3.893.893

Published: 1988

Journal Articles

Clinical investigation of human alpha interferon in chronic myelogenous leukemia

M Talpaz, HM Kantarjian, KB McCredie, MJ Keating, J Trujillo, J Gutterman

Blood (1987) 69 (5): 1280–1288.

https://doi.org/10.1182/blood.V69.5.1280.1280

Published: 1987

NARROW

Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment

p16INK4A and p15INK4B gene deletions in primary leukemias

Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia

Chronic myelogenous leukemia: a concise update

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia

2-Chlorodeoxyadenosine in the treatment of multiple myeloma [letter] [see comments]

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia

Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy [see comments]

Fludarabine therapy in macroglobulinemic lymphoma

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course

Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction

Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia

Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction

Clinical investigation of human alpha interferon in chronic myelogenous leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only